1.    新劢德自研产品 This product is independently designed and developed by Singmed.

2.    单剂量胶囊型DPI  Single Dose Capsule DPI

3.    新劢德设计与制造的装置已与中国多家头部上市制药企业开展生物等效性研究（采用诺华的三种药），已实现与原研装置的可替换。The self-developed Breezhaler® designed and manufactured by Singmed has been conducting Bioequivalence Researching (loaded with Indacaterol/Glycopyrronium Bromide/Indacaterol Maleate and Glycopyrronium Bromide produced by NOVARTIS) with a number of Chinese leading listed pharmaceutical companies, and has realized the replacement of the novel device.

4.    新劢德仿制装置规避了原研的专利限制，在保持与原研产品相同空气动力学机理的情况下，形成了新的设计和专利。

The generic device developed by Singmed circumvents the patent restrictions of the novel product, incorporating an innovating design and gaining our own patent while maintaining the same aerodynamic mechanism as the original product.